Xue Jun Su
Director/Board Member at SSY GROUP LIMITED
Net worth: 15 M $ as of 2024-05-30
Xue Jun Su active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SSY GROUP LIMITED | Director/Board Member | 2014-12-14 | - |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
 New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Director/Board Member | 2007-01-06 | - |
Career history of Xue Jun Su
Former positions of Xue Jun Su
| Companies | Position | Start | End |
|---|---|---|---|
| Shijiazhuang No 1 Pharmaceutical Factory | Corporate Officer/Principal | 1989-12-31 | - |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Director/Board Member | 2001-12-31 | - |
| Chairman | - | - | |
| Corporate Officer/Principal | 2001-12-31 | - |
Training of Xue Jun Su
| Hebei Normal University | Undergraduate Degree |
Statistics
International
| China | 4 |
| Hong Kong | 2 |
Operational
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Chairman | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SSY GROUP LIMITED | Health Technology |
| Private companies | 3 |
|---|---|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Health Technology |
| Shijiazhuang No 1 Pharmaceutical Factory | |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Finance |
- Stock Market
- Insiders
- Xue Jun Su
- Experience
